|
|
|
MIRA INFORM REPORT
|
Report No. : |
500726 |
|
Report Date : |
04.04.2018 |
IDENTIFICATION DETAILS
|
Name : |
BIOLOGICAL E. LIMITED (w.e.f. 03.10.1979) |
|
|
|
|
Formerly Known
As : |
BIOLOGICAL EVANS LIMITED |
|
|
|
|
Registered Office
: |
18/1 and 3, Azamabad, Hyderabad - 500020,
Telangana |
|
Tel. No.: |
91-40-30213999 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
10.12.1953 |
|
|
|
|
Com. Reg. No.: |
36-001095 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 49.500 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U01120TG1953PLC001095 |
|
|
|
|
IEC No.: |
Not Divulged |
|
|
|
|
GST No.: |
36AAACB7873P1Z0 |
|
|
|
|
TIN No.: |
36270101033 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACB7873P |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in Manufacturer and Seller of Vaccines and Pharmaceutical Formulations. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Not Available [We tried to
confirm the number of employees but no one is ready to part any information from
the company management] |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low risk
of default |
|
Maximum Credit Limit : |
USD 29996900 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated in the year 1953, and is engaged in manufacturing
and selling of Bulk drugs, formulations, Vaccines, etc. Management has failed to file its financials with the Registrar of
Companies for the FY 2017. As per the financial of 2016, the company has achieved revenue growth
of 6.53% as compared to the previous year along with a decent profit margin
of 31.04%. The rating takes into consideration sound financial profile of the
company marked by adequate net worth base along with strong debt coverage
indicators due to debt free balance sheet profile. Rating also takes into consideration the subject’s healthy Earnings
per Share of INR 6153 against the Face Value of INR 100. Rating takes into account the subject’s long established track record
of business operations along with extensive experience of its promoters. Payment seems to be regular. In view of aforesaid, the company can be considered good for business
dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
ICRA |
|
Rating |
Long Term Bank Facilities=AA |
|
Rating Explanation |
High degree of safety and very low credit
risk |
|
Date |
10.04.2017 |
|
|
|
|
Rating Agency Name |
ICRA |
|
Rating |
Short Term Bank Facilities=A1+ |
|
Rating Explanation |
Very Strong degree of safety and carry
lowest credit risk |
|
Date |
10.04.2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 04.04.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
MANAGEMENT NON-COOPERATIVE
(Contact No: 91-40-30214058)
LOCATIONS
|
Registered/ Head Office: |
18/1 and 3, Azamabad, Hyderabad - 500020,
Telangana, India |
|
Tel. No.: |
91-40-30213999/ 67388000/
27617831/ 30214058 |
|
Mobile No.: |
91-9618599333 (Mr. Venkat Rao Nelluri) |
|
Fax No.: |
91-40-27615309 |
|
E-Mail : |
mahipalreddy.saddi@biologicale.co.in
|
|
Website : |
|
|
|
|
|
Corporate Office : |
Road No. 35, Jubilee Hills, Hyderabad -
500033, Telangana, India |
|
Tel. No.: |
91-40-71216000 |
|
Fax No.: |
91-40-71216128/ 6030 |
|
|
|
|
Branch Office : |
Plot No.1, Phase-II, Alexandria Knowledge Park, Genome Valley, Kolthur
Village, Shameerpet Mandal, R.R District-500078, Hyderabad, India |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Ms. Indira Pusapati |
||||||||||||||||||||||||||||||
|
Designation : |
Whole Time Director |
||||||||||||||||||||||||||||||
|
Address : |
Plot No. 280/B, Road No. 25, Jubilee Hills, Hyderabad – 500033, Telangana,
India |
||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
19.21.1971 |
||||||||||||||||||||||||||||||
|
Qualification : |
M.B.B.S. |
||||||||||||||||||||||||||||||
|
Date of Appointment : |
09.04.2013 |
||||||||||||||||||||||||||||||
|
DIN No.: |
00482381 |
||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Name : |
Ms. Mahima Datla |
||||||||||||||||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||||||||||||||||
|
Address : |
Plot No. 350, Road No. 25, Jubilee hills, Hyderabad – 500033, Telangana,
India |
||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
16.07.1977 |
||||||||||||||||||||||||||||||
|
Qualification : |
BBA |
||||||||||||||||||||||||||||||
|
Date of Appointment : |
09.04.2013 |
||||||||||||||||||||||||||||||
|
PAN No.: |
AGJPD1584F |
||||||||||||||||||||||||||||||
|
DIN No.: |
00965039 |
||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Name : |
Mrs. Purnima Mantena |
||||||||||||||||||||||||||||||
|
Designation : |
Whole Time Director |
||||||||||||||||||||||||||||||
|
Address : |
Plot No. 350, Road No. 23, Jubilee Hills, Hyderabad – 500033, Telangana,
India |
||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
09.08.1970 |
||||||||||||||||||||||||||||||
|
Qualification : |
Graduate |
||||||||||||||||||||||||||||||
|
Date of Appointment : |
10.04.2013 |
||||||||||||||||||||||||||||||
|
DIN No.: |
00965007 |
||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Saddi Mahipal Reddy |
|
Designation : |
Company Secretary |
|
Address : |
H. No. 8-5-188/2, Plot No. 17, Road No. 5, Mallikarjuna
Colony, Old Bowenpally, Secunderabad-500011, Andhra Pradesh, India |
|
Date of Birth/Age : |
05.04.1965 |
|
Qualification : |
CS |
|
Date of Appointment : |
23.12.2014 |
|
PAN No.: |
AOYPS7663B |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 31.03.2016
|
Names of Shareholders |
No. of Shares |
|
Mahima Datla |
413293 |
|
Mahima Datla and Renuka Datla |
14172 |
|
Poornima Mantena |
5505 |
|
Indira P. Raju |
5506 |
|
Vijay Kumar Datla and (Trustee Purnima and Indu Trust) |
1999 |
|
Vijay Kumar Datla and (Trustee of Mahima Trust) |
1685 |
|
Poornima, Indira and Mahima |
187 |
|
Vijay Kumar Datla and Renuka Datla |
5813 |
|
Renuka Datla and Mahima Datla |
26995 |
|
V.R. Investments and Finance Private Limited |
18425 |
|
Purnedu Gupta and Krishna Gupta |
250 |
|
Narender Dev Mantena |
11 |
|
Sridhar P. Raju |
11 |
|
Renuka Datla |
1148 |
|
|
|
|
Total |
495000 |
AS ON 17.12.2016
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters
– Individual/Hindu Undivided Family (Indian) |
95.53 |
|
Promoters
– Body Corporate |
3.73 |
|
Promoters
– Others |
0.74 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in Manufacturer and Seller of Vaccines and Pharmaceutical Formulations. [Registered Activity] |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Not Divulged |
||||
|
|
|
||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS: (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||
|
|
|
||||||||||||||
|
Customers : |
|
||||||||||||||
|
|
|
||||||||||||||
|
No. of Employees : |
Not Available [We tried to
confirm the number of employees but no one is ready to part any information
from the company management] |
||||||||||||||
|
|
|
||||||||||||||
|
Bankers : |
· Bank of Baroda Abids Circle, Secundrabd, Andhra Pradesh, India ·
The Lakshmi Vilas Bank Limited 5-1-716/1, 1st Floor, Bank Street, Hyderabad – 500195, Andhra Pradesh, India ·
Bank of India PTI Building, A.C. Guards, Khairtabad, Hyderabad-500004, Andhra Pradesh, India · ICICI Bank Limited Land, Mark, Race Cource Circle, Alkapuri, Baroda-390015, Gujarat, India · Bank of Baroda Bank Street, Hyderabad, Andhra Pradesh, India · Andhra Bank Sultan Bazar Branch,, Sultan Bazar, Koti,, Hyderabad - 500195, Andhra Pradesh, India · State Bank of India Mid Corporate Loan Admin. Unit, Hyderguda, Hyderabad - 500029, Andhra Pradesh, India |
||||||||||||||
|
|
|
||||||||||||||
|
Facilities : |
--- |
|
Financial Institutions : |
New Marine Lines, Mumbai, Maharashtra, India
7/154 Swarup Nagar, Kanpur, Uttar Pradesh, India |
|
|
|
|
Auditors : |
|
|
Name : |
Brahmayya and Company Chartered Accountants |
|
Address : |
Flat No. 403 and 404, Golden Green Apartment, Errum Manzil Colony, Hyderabad
- 500082, Telangana, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AADFB8032G |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Others Related Parties : |
· Raju Investments Private Limited, India [U74899DL1977PTC008553] · D.A.P. Containers Private Limited, India [U21020TG1976PTC001643] · B E Immuno Sciences Private Limited, India [U24230TG1999PTC031761] ·
Be Vaccine Sas |
|
|
|
|
Subsidiary Companies : |
· Biotech Medicals Private Limited (U24230TG1999PTC032680) · B.E. Investment and Finance Private Limited (U65993TG1987PTC008036) · BE Vaccine Pte Limited Singapore · Vaxenic India Private Limited, India [U74900TG2015PTC097587] ·
BE Vaccines Private Limited |
|
|
|
|
Joint Venture : |
Qualivax Pte Limited |
|
|
|
|
Directors interested as Trustees : |
·
Purnima Trust ·
Indira Trust ·
Mahima Trust · Purnima and Indira Trust |
|
|
|
|
Firms in which relatives of Key
Management Personnel are interested : |
· Raju Investments * · Bharathi Trust · Biotech Pharma · BE Research Centre |
|
|
|
|
Companies in which Key Management
Personnel are interested : |
· D A P Containers Private Limited* · V.R. Packing Co. Private Limited* · V.R.Constructions Private Limited* · V R Transport Co Private Limited* · Vasistha Technologies Private Limited* · BE Animal Health Private Limited* · BE Immunosciences Private Limited* · V.R.Real Estate Private Limited · V R Farms Private Limited · V.R.Investments & Finance Private Limited · Eureka Laboratories Private Limited · Techno Pharma Private Limited · Auris Holdings & Infrastructure Private Limited · BE Chemicals Private Limited · BE Pharma Private Limited · Biotech Pharma Private Limited · Biona Health Care Private Limited · Biona Herbal Research Centre Private Limited · Hitech Medicals Private Limited |
Note:
* Firms / Companies with which there are
transactions during the year and / or balances outstanding as at the end of the
year.
CAPITAL STRUCTURE
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
500000 |
Equity Shares |
INR 100/- each |
INR 50.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
495000 |
Equity Shares |
INR 100/- each |
INR 49.500
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
49.500 |
49.500 |
49.500 |
|
(b) Reserves and Surplus |
10449.438 |
7415.598 |
3983.243 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
10498.938 |
7465.098 |
4032.743 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
62.012 |
|
(b) Deferred tax liabilities (Net) |
525.703 |
487.105 |
379.347 |
|
(c) Other long-term
liabilities |
472.845 |
472.845 |
472.845 |
|
(d) long-term
provisions |
26.221 |
13.502 |
26.085 |
|
Total Non-current
Liabilities (3) |
1024.769 |
973.452 |
940.289 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade
payables |
864.709 |
563.982 |
342.679 |
|
(c) Other
current liabilities |
2540.594 |
2903.887 |
2713.373 |
|
(d) Short-term
provisions |
214.199 |
384.374 |
235.103 |
|
Total Current
Liabilities (4) |
3619.502 |
3852.243 |
3291.155 |
|
|
|
|
|
|
TOTAL |
15143.209 |
12290.793 |
8264.187 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
3343.433 |
3408.177 |
2924.634 |
|
(ii) Intangible
Assets |
32.556 |
17.354 |
0.951 |
|
(iii) Tangible assets
capital work-in-progress |
1862.682 |
621.817 |
182.128 |
|
(iv)
Intangible assets under development |
26.320 |
20.162 |
0.000 |
|
(b) Non-current Investments |
2791.053 |
2165.320 |
551.672 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term
loans and advances |
296.518 |
230.434 |
173.474 |
|
(e) Other
Non-current assets |
779.304 |
135.145 |
0.000 |
|
Total Non-Current
Assets |
9131.866 |
6598.409 |
3832.859 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
120.000 |
80.000 |
|
(b)
Inventories |
3095.145 |
2084.215 |
1622.072 |
|
(c) Trade
receivables |
1190.633 |
1058.743 |
1022.635 |
|
(d) Cash and bank
balances |
1116.827 |
2006.386 |
1544.893 |
|
(e)
Short-term loans and advances |
595.341 |
410.661 |
148.306 |
|
(f) Other
current assets |
13.397 |
12.379 |
13.422 |
|
Total
Current Assets |
6011.343 |
5692.384 |
4431.328 |
|
|
|
|
|
|
TOTAL |
15143.209 |
12290.793 |
8264.187 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
9811.350 |
9209.824 |
6976.502 |
|
|
Other Income |
368.471 |
822.312 |
218.977 |
|
|
TOTAL |
10179.821 |
10032.136 |
7195.479 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
1132.265 |
1174.774 |
1120.928 |
|
|
Purchases of
Stock-in-Trade |
111.474 |
105.215 |
91.218 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(708.309) |
(415.879) |
(658.199) |
|
|
Employee benefit expense |
1424.130 |
1114.974 |
857.879 |
|
|
Expenditure on production, transportation
and Other expenditure pertaining to
exploration and production activities |
0.000 |
0.000 |
292.987 |
|
|
CSR expenditure |
12.800 |
0.000 |
0.000 |
|
|
Other expenses |
4016.061 |
2812.508 |
1842.123 |
|
|
TOTAL |
5988.421 |
4791.592 |
3546.936 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
4191.400 |
5240.544 |
3648.543 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
6.964 |
11.723 |
146.108 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
4184.436 |
5228.821 |
3502.435 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
320.141 |
257.015 |
191.583 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
3864.295 |
4971.806 |
3310.852 |
|
|
|
|
|
|
|
Less |
TAX |
818.540 |
1457.420 |
934.070 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
3045.755 |
3514.386 |
2376.782 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
6153.04 |
7100.00 |
4802.00 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
0.000 |
0.000 |
12.700 |
|
|
|
|
|
|
Net cash flows from (used in) operations |
2858.894 |
4682.398 |
2891.528 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
2820.869 |
4667.628 |
2611.400 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
44.29 |
41.96 |
53.50 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
8.24 |
8.70 |
6.82 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
253.77 |
160.82 |
103.19 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
1.35 |
2.51 |
2.25 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.80 |
1.29 |
1.17 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.24 |
0.31 |
0.41 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.00 |
0.00 |
0.02 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.34 |
0.52 |
0.82 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.50 |
0.54 |
0.77 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
601.87 |
447.03 |
24.97 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
31.04 |
38.16 |
34.07 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
20.11 |
28.59 |
28.76 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
29.01 |
47.08 |
58.94 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.66 |
1.48 |
1.35 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.81 |
0.94 |
0.85 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.69 |
0.61 |
0.49 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
0.00 |
0.00 |
1.51 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.66 |
1.48 |
1.35 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL DATA
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
49.500 |
49.500 |
49.500 |
|
Reserves & Surplus |
3983.243 |
7415.598 |
10449.438 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
4032.743 |
7465.098 |
10498.938 |
|
|
|
|
|
|
Long-term borrowings |
62.012 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
CURRENT MATURITIES OF
LONG-TERM DEBTS |
12.700 |
0.000 |
0.000 |
|
Total
borrowings |
74.712 |
0.000 |
0.000 |
|
Debt/Equity
ratio |
0.019 |
0.000 |
0.000 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
6976.502 |
9209.824 |
9811.350 |
|
|
|
32.012 |
6.531 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
6976.502 |
9209.824 |
9811.350 |
|
Profit |
2376.782 |
3514.386 |
3045.755 |
|
|
34.07% |
38.16% |
31.04% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
G30567192 |
100049884 |
SBICAP TRUSTEE COMPANY LIMITED |
09/08/2016 |
17/11/2016 |
- |
2680000000.0 |
202, Maker Tower ECuffe ParadeMumbaiMH400005IN |
|
2 |
Y10369074 |
90260988 |
UNIT TRUST OF INDIA |
10/02/1993 |
15/04/1993 |
- |
20000000.0 |
NEW MARINE LINESMUMBAIMHIN |
|
3 |
Y10369062 |
90260976 |
KOTAK MAHINDRA BANK LIMITED |
18/01/1993 |
- |
- |
1400000.0 |
CHKDAPALLY DEDERBADHYDERABADAPIN |
|
4 |
Y10368917 |
90260831 |
UNIT TRUST OF INDIA |
11/06/1990 |
- |
- |
600000.0 |
13; SHRI VITHALDAS THAKREY MARGNEW MARINE LINESMUMBAIMHIN |
|
5 |
Y10371302 |
90263216 |
UTTAR PRADESH FINANCIAL CORP. |
24/08/1973 |
- |
- |
60000.0 |
CIVIL LINESKANPURUPIN |
|
6 |
Y10368533 |
90260447 |
UTTAR PRADESH FINANCIAL CORPORATION |
11/08/1971 |
- |
- |
375000.0 |
7/154 SWARUP NAGARKANPURUPIN |
|
7 |
C04591509 |
10484517 |
BANK OF INDIA |
24/01/2011 |
- |
27/05/2014 |
227455500.0 |
PTI BUILDING, A.C. GUARDSKHAIRTABADHYDERABADAP500004IN |
|
8 |
B97966469 |
10275258 |
ICICI BANK LIMITED |
25/03/2011 |
04/08/2011 |
04/03/2014 |
2568000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
9 |
B97968218 |
10279463 |
ICICI BANK LIMITED |
16/04/2011 |
12/09/2012 |
04/03/2014 |
2405000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
10 |
B97087662 |
90257838 |
BANK OF BARODA |
31/10/1992 |
18/01/2008 |
20/02/2014 |
120000000.0 |
HYDERABAD MAIN BRANCHHANUMAN TKEDI, ABIDSHYDERABADAP500001IN |
BUSINESS REVIEW AND
PERFORMANCE:
Sales (net of excise duty collected) & other income for the financial year ended 31st March, 2016 is INR 10180.000 Million as against INR 10032.000 Million for the financial year ended 31st March, 2015 reflecting a growth of 1.45% year-on-year.
The operational profit for the financial year 2015-16 is INR 3864.000 Million as against INR 4972.000 Million for the financial year ended 31st March, 2015 and the Net Profit after tax and after prior period adjustments was INR 3046.000 Million as against INR 3514.000 Million for the previous year. There is a decrease in net profit of 468.000 Million amounting to 13.32% due to allocation of consumption of stores and spares and the management is confident that the added stores and spares will generate good revenue in the FY 2016-17.
FIXED ASSETS:
Tangible Assets
·
Land
·
Buildings
·
Plant and Equipment
·
Furniture and Fixtures
·
Vehicles
·
Office Equipment
·
Computer Equipments
PRESS RELEASE :
BIOLOGICAL E. LIMITED TO INVEST INR 3000.000 Million IN NEW VACCINES
PLANT IN HYDERABAD
Biological E. Limited (BE) will
invest INR 3000.000 MILLION in a new vaccine plant at Genome Valley here
February 6, 2017
It is scheduled to be completed by April next year while commercial production is expected to begin by December 2019. (Site)
Biological E. Limited (BE) will invest INR 3000.000 Million in a new vaccine plant at Genome Valley here. It is scheduled to be completed by April next year while commercial production is expected to begin by December 2019.
BE Managing Director Mahima Datla said the new plant will help augment the company’s vaccine production capacity as well as manufacture new products that are in the pipeline. She said the initial investment of INR 3000.000 Million was in line with and part of the already earmarked overall outlay of INR 10000.000 Million in the Genome Valley across BE’s vaccines and pharma businesses.
The expansion of BE’s facility is expected to create jobs for around 1,000 people.
Paul Stoffels, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson (J&J) and Soumya Swaminathan, Director General, Indian Council of Medical Research, were present on the occasion.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.02 |
|
|
1 |
INR 91.46 |
|
Euro |
1 |
INR 80.09 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
PRY |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not be considered as unfavorable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.